Dr. August Reader, MD

NPI: 1053312157
Total Payments
$1,852
2024 Payments
$25.06
Companies
13
Transactions
36
Medicare Patients
1,186
Medicare Billing
$85,663

Payment Breakdown by Category

Food & Beverage$939.74 (50.8%)
Other$911.92 (49.2%)

Payments by Nature

Nature of Payment Amount Transactions Share
Food and Beverage $939.74 35 50.8%
Long term medical supply or device loan $911.92 1 49.2%

Top Paying Companies

Company Total Records Latest Year
Carl Zeiss Meditec USA, Inc. $911.92 1 $0 (2022)
TISSUETECH, INC. $352.50 9 $0 (2021)
Allergan, Inc. $148.21 7 $0 (2020)
ABBVIE INC. $128.59 4 $0 (2023)
Genentech USA, Inc. $70.40 3 $0 (2019)
Regeneron Healthcare Solutions, Inc. $65.22 3 $0 (2019)
Shire North American Group Inc $35.16 2 $0 (2018)
Bausch & Lomb, a division of Bausch Health US, LLC $34.86 2 $0 (2020)
BioTissue Holdings, Inc. $29.52 1 $0 (2022)
Amgen Inc. $25.06 1 $0 (2024)

Payment History by Year

Year Amount Transactions Top Company
2024 $25.06 1 Amgen Inc. ($25.06)
2023 $104.30 3 ABBVIE INC. ($104.30)
2022 $965.73 3 Carl Zeiss Meditec USA, Inc. ($911.92)
2021 $58.61 2 TISSUETECH, INC. ($43.85)
2020 $117.26 6 Allergan, Inc. ($64.66)
2019 $299.05 10 TissueTech, Inc. ($153.78)
2018 $102.59 4 TissueTech, Inc. ($63.80)
2017 $179.06 7 TissueTech, Inc. ($69.64)

All Payment Transactions

36 individual payment records from CMS Open Payments — Page 1 of 2

Date Company Product Nature Form Amount Type
06/08/2024 Amgen Inc. TEPEZZA (Biological) Food and Beverage In-kind items and services $25.06 General
Category: Inflammation/Rare Disease
12/14/2023 ABBVIE INC. DURYSTA (Drug) Food and Beverage In-kind items and services $34.39 General
Category: EYE CARE
08/25/2023 ABBVIE INC. DURYSTA (Drug) Food and Beverage In-kind items and services $34.93 General
Category: EYE CARE
03/27/2023 ABBVIE INC. DURYSTA (Drug) Food and Beverage In-kind items and services $34.98 General
Category: EYE CARE
07/13/2022 BioTissue Holdings, Inc. PROKERA (Device), AMNIOGRAFT Food and Beverage In-kind items and services $29.52 General
Category: HUMAN TISSUE PRODUCTS
06/30/2022 Carl Zeiss Meditec USA, Inc. CLARUS (Device) Long term medical supply or device loan In-kind items and services $911.92 General
Category: Fundus Camera
06/16/2022 ABBVIE INC. DURYSTA (Drug) Food and Beverage In-kind items and services $24.29 General
Category: GLAUCOMA
08/06/2021 TISSUETECH, INC. PROKERA (Device), AMNIOGRAFT Food and Beverage In-kind items and services $43.85 General
Category: HUMAN TISSUE PRODUCTS
07/22/2021 Sight Sciences, Inc. TearCare SmartLid (Device), TEARCARE(TM) (2.2) SYSTEM KIT Food and Beverage In-kind items and services $14.76 General
Category: Ophthalmology
11/30/2020 TissueTech, Inc. Prokera (Device), AmnioGraft, AmnioGuard Food and Beverage Cash or cash equivalent $21.43 General
Category: Medical Device (510K)
11/18/2020 Allergan, Inc. DURYSTA (Drug) Food and Beverage In-kind items and services $17.66 General
Category: GLAUCOMA
11/09/2020 Aerie Pharmaceuticals, Inc. rocklatan (Drug), rhopressa Food and Beverage In-kind items and services $17.41 General
Category: Glaucoma
08/06/2020 Allergan, Inc. DURYSTA (Drug) Food and Beverage In-kind items and services $22.82 General
Category: GLAUCOMA
05/31/2020 Allergan, Inc. DURYSTA (Drug) Food and Beverage In-kind items and services $24.18 General
Category: GLAUCOMA
03/11/2020 Bausch & Lomb, a division of Bausch Health US, LLC VYZULTA (Drug) Food and Beverage In-kind items and services $13.76 General
Category: OPHTHALMOLOGY
12/11/2019 Genentech USA, Inc. Lucentis (Biological) Food and Beverage In-kind items and services $24.82 General
Category: Ophthalmology
12/04/2019 Allergan Inc. LUMIGAN (Drug) Food and Beverage In-kind items and services $18.10 General
Category: OPHTHALMOLOGY
11/05/2019 Bausch & Lomb, a division of Bausch Health US, LLC VYZULTA (Drug) Food and Beverage In-kind items and services $21.10 General
Category: OPHTHALMOLOGY
10/17/2019 Kala Pharmaceuticals, Inc. INVELTYS (Drug) Food and Beverage In-kind items and services $18.05 General
Category: OCULAR
08/10/2019 TissueTech, Inc. Prokera (Device), AmnioGraft, AmnioGuard Food and Beverage Cash or cash equivalent $78.95 General
Category: Medical Device (510K)
06/12/2019 Genentech USA, Inc. Lucentis (Biological) Food and Beverage In-kind items and services $24.11 General
Category: Ophthalmology
06/07/2019 TissueTech, Inc. Prokera (Device), AmnioGraft, AmnioGuard Food and Beverage Cash or cash equivalent $29.39 General
Category: Medical Device (510K)
05/20/2019 Allergan Inc. LUMIGAN (Drug) Food and Beverage In-kind items and services $19.25 General
Category: OPHTHALMOLOGY
02/22/2019 Regeneron Healthcare Solutions, Inc. EYLEA (Biological) Food and Beverage In-kind items and services $19.84 General
Category: OPHTHALMOLOGY
02/13/2019 TissueTech, Inc. Prokera (Device), AmnioGraft, AmnioGuard Food and Beverage Cash or cash equivalent $45.44 General
Category: Medical Device (510K)

Medicare Billing by Year

Year Procedures Beneficiaries Services Submitted Medicare Paid
2022 5 154 159 $28,590 $10,606
2021 10 527 583 $102,560 $49,369
2020 14 505 580 $79,970 $25,688
Total Patients
1,186
Total Services
1,322
Medicare Billing
$85,663
Procedure Codes
29

All Medicare Procedures & Services

29 procedure records from CMS Medicare Utilization — Page 1 of 2

HCPCS Description Setting Year Patients Services Charges Medicare Paid Ratio
92014 Established patient complete exam of visual system Office 2022 40 40 $8,000 $3,783 47.3%
92012 Established patient problem focused exam of visual system Office 2022 41 46 $5,750 $2,945 51.2%
92004 New patient complete exam of visual system Office 2022 13 13 $2,925 $1,461 49.9%
92083 Exam of visual field with extended testing Office 2022 31 31 $7,130 $1,433 20.1%
92250 Photography of the retina Office 2022 29 29 $4,785 $983.71 20.6%
92014 Eye and medical examination for diagnosis and treatment, established patient, 1 or more visits Office 2021 194 199 $39,800 $23,509 59.1%
92012 Eye and medical examination for diagnosis and treatment, established patient Office 2021 77 105 $13,125 $9,353 71.3%
92083 Measurement of field of vision during daylight conditions, extended examination Office 2021 82 87 $20,010 $5,344 26.7%
92004 Eye and medical examination for diagnosis and treatment, new patient, 1 or more visits Office 2021 22 22 $4,950 $3,009 60.8%
92250 Photography of the retina Office 2021 63 65 $10,725 $2,356 22.0%
92134 Diagnostic imaging of retina Office 2021 27 34 $4,250 $1,348 31.7%
99213 Established patient outpatient visit, total time 20-29 minutes Office 2021 15 20 $2,300 $1,339 58.2%
99214 Established patient outpatient visit, total time 30-39 minutes Office 2021 11 11 $1,925 $1,196 62.2%
92060 Measurement of eye muscles to detect deviation of eyeball Office 2021 15 19 $2,850 $1,192 41.8%
92133 Diagnostic imaging of optic nerve of eye Office 2021 21 21 $2,625 $722.22 27.5%
92012 Eye and medical examination for diagnosis and treatment, established patient Office 2020 97 112 $14,000 $4,751 33.9%
92014 Eye and medical examination for diagnosis and treatment, established patient, 1 or more visits Office 2020 64 64 $12,800 $4,313 33.7%
92083 Measurement of field of vision during daylight conditions Office 2020 72 96 $17,780 $3,930 22.1%
99213 Established patient office or other outpatient visit, typically 15 minutes Office 2020 35 38 $4,370 $2,700 61.8%
99212 Established patient office or other outpatient visit, typically 10 minutes Office 2020 34 38 $2,850 $1,621 56.9%
99442 Physician telephone patient service, 11-20 minutes of medical discussion Office 2020 19 19 $2,185 $1,385 63.4%
92133 Diagnostic imaging of optic nerve of eye Office 2020 35 46 $4,455 $1,140 25.6%
92060 Measurement of eye muscles to detect deviation of eyeball Office 2020 25 25 $3,690 $1,134 30.7%
99441 Physician telephone patient service, 5-10 minutes of medical discussion Office 2020 22 25 $1,875 $1,084 57.8%
92250 Photography of the retina Office 2020 28 33 $4,620 $1,063 23.0%

About Dr. August Reader, MD

Dr. August Reader, MD is a Ophthalmology healthcare provider based in San Francisco, California. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 08/10/2005. The National Provider Identifier (NPI) number assigned to this provider is 1053312157.

According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. August Reader, MD has received a total of $1,852 in payments from pharmaceutical and medical device companies, with $25.06 received in 2024. These payments were reported across 36 transactions from 13 companies. The most common payment nature is "Food and Beverage" ($939.74).

As a Medicare-enrolled provider, Reader has provided services to 1,186 Medicare beneficiaries, totaling 1,322 services with total Medicare billing of $85,663. Data is available for 3 years (2020–2022), covering 29 distinct procedure/service records.

Practice Information

  • Specialty Ophthalmology
  • Location San Francisco, CA
  • Active Since 08/10/2005
  • Last Updated 07/13/2007
  • Taxonomy Code 207W00000X
  • Entity Type Individual
  • NPI Number 1053312157

Products in Payments

  • CLARUS (Device) $911.92
  • Prokera (Device) $308.65
  • DURYSTA (Drug) $193.25
  • PROKERA (Device) $73.37
  • Lucentis (Biological) $70.40
  • EYLEA AFLIBERCEPT INJECTION (Biological) $45.38
  • LUMIGAN (Drug) $37.35
  • XIIDRA (Drug) $35.16
  • VYZULTA (Drug) $34.86
  • TEPEZZA (Biological) $25.06
  • RESTASIS (Drug) $21.41
  • EYLEA (Biological) $19.84
  • INVELTYS (Drug) $18.05
  • rocklatan (Drug) $17.41
  • TearCare SmartLid (Device) $14.76

Data Sources

Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.

Ophthalmology Doctors in San Francisco